also it makes sense that IP is the security as current US$35m may be secured against the Japan GvHD and Tigenix related IP, but to get the next US$15m and then US$25m company needs to meet certain milestones which likely could be related to the US GvHD trial, the CHF LVAD trial and perhaps the back pain Phase 3 trial .. each of these if pass their next inflexion point will be de-risked which means they should then be considered as relatively de-risked IP as security for the additional loan draw downs..
Ann: MSB Enters Into $75 Million Non-Dilutive Credit Facility, page-132
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |